| Name | 4-[1-[[2,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]thiophene-3-carbonyl]amino]cyclopropyl]benzoic acid |
|---|---|
| Synonyms |
MK-2894||MK2894
MK-2894 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid CS-0679 |
| Description | MK-2894 is a highly potent and selective second generation EP4 antagonist.IC50 value:Target: EP4MK-2894 exhibits favorable pharmacokinetic profile in a number of preclinical species and potent anti-inflammatory activity in several animal models of pain/inflammation. MK-2894 also shows favorable GI tolerability profile in rats when compared to traditional NSAID indomethacin. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C25H22F3NO3S |
|---|---|
| Molecular Weight | 473.50700 |
| Exact Mass | 473.12700 |
| PSA | 98.13000 |
| LogP | 6.66660 |
| Storage condition | 2-8℃ |